Formulary Monographs [ETOPOSIDE, 1000]
|
|
ETOPOSIDE
|
|
|
|
|
|
ANTINEOPLASTICS
|
|
|
Small cell carcinoma of the bronchus, the lymphomas and testicular cancer.
|
|
|
Alopecia; bone-marrow supp ression.
|
|
|
Adult: Orally , 120–240 mg/m2 daily for 5 days.
|
|
|
|
|
|
Etoposide may cause fetal harm when administered to pregnant women, but potential benefits from use of the drug may be acceptable in certain conditions despite possible risks to the fetus.
|
|
|
Unknown. Breastfeeding is not recommended.
|
|
|
|